P+P advises EQT on the management participation in the sale of BSN medical to the Swedish SCA
Private equity investor EQT has sold the Hamburg medical device manufacturer BSN medical to the Swedish Svenska Cellulosa Aktiebolaget (SCA). The purchase price is EUR 2.74 billion; the transaction is still subject to the approval of the competent antitrust authorities.
BSN medical is the leading global supplier of integrated medical therapy solutions with medical devices in the areas of wound care (including leukoplast), vascular disease, lymphology and non-invasive orthopedics. Founded in 2001, the company, which has 6000 employees, generated an annual turnover of EUR 861 million and operating profit of EUR 137 million.
In August 2012, EQT acquired a majority stake in BSN medical for EUR 1.8 billion from the investment company Montagu.
P+P Pöllath + Partners advised EQT on the management participation with the following Munich team:
- Dr. Benedikt Hohaus (partner, M&A/private equity)
- Dr. Barbara Koch-Schulte (partner, tax)
- Sebastian Sumalvico (associate, tax, M&A/private equity)
